ArticleScientific reports2025
A promising AI based super resolution image reconstruction technique for early diagnosis of skin cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- R3MV: a novel reliable system architecture for skin cancer classification using progressive heterogeneous multiblock model.Scientific reports · 2026Article
- Enhanced skin cancer classification for minority classes using Conditional GAN pipeline and CNN-ViT ensemble.Scientific reports · 2026Article
- Generative Adversarial Networks in Dermatology: A Narrative Review of Current Applications, Challenges, and Future Perspectives.Bioengineering (Basel, Switzerland) · 2025Review
- Semi-supervised GAN with hybrid regularization and evolutionary hyperparameter tuning for accurate melanoma detection.Scientific reports · 2025Article
- Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma.Biosensors · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer can be prevalent in people of any age group who are exposed to ultraviolet (UV) radiation. Among all other types, melanoma is a notable severe kind of skin cancer, which can be fatal. Melanoma is a malignant skin cancer arising from melanocytes, requiring early detection. Typically, skin lesions are classified either as benign or malignant. However, some lesions do exist that don't show clear cancer signs, making them suspicious. If unnoticed, these suspicious lesions develop into severe melanoma, requiring invasive treatments later on. These intermediate or suspicious skin lesions are completely curable if it is diagnosed at their early stages. To tackle this, few researchers intended to improve the image quality of the infected lesions obtained from the dermoscopy through image reconstruction techniques. Analyzing reconstructed super-resolution (SR) images allows early detection, fine feature extraction, and treatment plans. Despite advancements in machine learning, deep learning, and complex neural networks enhancing skin lesion image quality, a key challenge remains unresolved: how the intricate textures are obtained while performing significant up scaling in medical image reconstruction? Thus, an artificial intelligence (AI) based reconstruction algorithm is proposed to obtain the fine features from the intermediate skin lesion from dermoscopic images for early diagnosis. This serves as a non-invasive approach. In this research, a novel melanoma information improvised generative adversarial network (MELIIGAN) framework is proposed for the expedited diagnosis of intermediate skin lesions. Also, designed a stacked residual block that handles larger scaling factors and the reconstruction of fine-grained details. Finally, a hybrid loss function with a total variation (TV) regularization term switches to the Charbonnier loss function, a robust substitute for the mean square error loss function. The benchmark dataset results in a structural index similarity (SSIM) of 0.946 and a peak signal-to-noise ratio (PSNR) of 40.12 dB as the highest texture information, evidently compared to other state-of-the-art methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.